Document is current
Any future updates will be listed below
-
Authors
Kanu, Chisom https://orcid.org/0000-0002-2621-8652
Al-Zubeidi, Tamara
Shinde, Shraddha
Al-Jassar, Gemma
Poon, Jiat Ling
Miller, Jordan
Marshall, Chris
Carmichael, Chloe
-
Funding
Funding for this research was provided by:
Eli Lilly and Company (Eli Lilly and Company)
- License Information
-
More Information
Article History
Received: 6 November 2024
Accepted: 6 January 2026
First Online: 21 January 2026
Declarations
:
: This study received approval from an institutional review board and was performed in accordance with the ethical principles of the Declaration of Helsinki. All participants provided written informed consent.
: Participant data has been anonymized, and participants were informed that if information about this study was published, they would not be identified.
: The authors, TAZ, GAJ, JM, CM and CC are current employees and stockholders of Clarivate, a health economic and outcomes research consultancy that consults with various pharmaceutical and biotech companies and were paid consultants to Eli Lilly and Company in connection with this study. The authors CK, SS, and JLP are employees and shareholders at Eli Lilly and Company.
